At current share prices, it wouldn't move the OS that much. This is great because it means they are gearing up for phase II. Phase I should be a cake walk as it looks like there aren't going to be any concerns over safety/efficacy. Positive phase I can launch this to $4-$5. Just look at what happened with innovation pharm back when they had positive phase I results for their ovarian cancer drug. Their OS is identical to ours too.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.